Updated: January 4, 2026
Ovide Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Is Ovide (malathion) in a shortage in 2026? Here's the latest status, what's causing availability problems, and what patients should do right now.
Patients trying to fill an Ovide (malathion) prescription often encounter empty shelves and confused pharmacists. If you're wondering whether there's an official shortage — or just trying to understand why this prescription lice treatment is so hard to find — here's what you need to know.
Is Ovide in an Official FDA Shortage in 2026?
As of 2026, Ovide (malathion 0.5% lotion) is NOT listed on the FDA's official drug shortage database. This means there is no designated national manufacturing or supply shortage for this medication. Malathion is manufactured by Taro Pharmaceuticals U.S.A., Inc. and is technically available through the pharmaceutical supply chain.
However — and this is the critical distinction — "not in a shortage" does not mean "easy to find." Ovide's availability challenges are structural, not a supply chain emergency. Understanding the difference helps you take the right steps.
Why Ovide Is Hard to Find Even Without a Shortage
The availability problem with Ovide comes down to market dynamics:
Low and intermittent demand. Ovide is primarily a second- or third-line treatment for treatment-resistant head lice. Because it's not frequently prescribed, most pharmacies see little reason to stock it.
High retail cost. A 59 mL bottle of Ovide retails for around $250, which means pharmacies tie up significant capital in slow-moving inventory.
Flammability requirements. The 78% isopropyl alcohol base makes Ovide flammable, requiring specific storage considerations that may discourage some pharmacies.
Seasonal spikes. Head lice infestations increase in late summer and early fall as school starts, creating surges in demand that can temporarily overwhelm limited local stocks.
History of Ovide's Availability Challenges
Ovide has experienced periodic availability issues over the years. The drug was first approved in 1982, and a generic malathion lotion became available in 2009. Generic competition helped improve overall supply availability, but the fundamental stocking challenge remained: pharmacies that don't regularly fill malathion prescriptions simply don't keep it on hand.
Unlike medications in shortage due to manufacturing problems or raw material issues, Ovide's supply chain from manufacturer to wholesaler is largely intact. The gap is in the "last mile" — pharmacies aren't ordering enough because demand signals are too weak.
What This Means for You as a Patient
If you're dealing with a head lice infestation and can't find Ovide, here are the most practical steps to take right now:
Don't assume it's unavailable everywhere. Ovide may be in stock at a pharmacy you haven't tried yet. Call multiple pharmacies or use a service like medfinder to check availability across locations near you.
Ask for generic malathion. Some pharmacies carry generic malathion lotion 0.5% but not brand-name Ovide — or vice versa. Asking for both increases your chances of success.
Request a special order. Most pharmacies can order Ovide from their wholesaler within 1-2 business days. This is often the fastest route to getting your prescription filled.
Consider mail-order options. Services like Express Scripts or CVS Caremark can often source and deliver medications like Ovide that aren't available at local pharmacies.
Ask about alternatives. If access remains a problem, talk to your doctor about substituting spinosad (Natroba) or ivermectin lotion (Sklice), both of which are ovicidal and generally more accessible.
How medfinder Can Help
Rather than spending hours calling pharmacies yourself, medfinder contacts pharmacies near you to find which ones can fill your Ovide or malathion prescription. You provide your medication, dosage, and location — and results are texted directly to you. It's designed specifically for situations like this.
The Bottom Line
Ovide is not in an official FDA shortage as of 2026. Its availability challenges are structural — a low-demand prescription product that pharmacies don't routinely stock. With the right approach, you can find it. Start by checking multiple pharmacies, asking for generic malathion, and using tools like medfinder. For a step-by-step guide, see: How to Find Ovide in Stock Near You
Frequently Asked Questions
No. As of 2026, Ovide (malathion 0.5% lotion) is not on the FDA's official drug shortage list. The manufacturer, Taro Pharmaceuticals, continues to produce and distribute the product. Availability problems at the pharmacy level are due to low demand and inconsistent stocking — not a manufacturing or supply chain shortage.
Ovide is a niche prescription drug primarily used when first-line lice treatments fail. Because demand is low and sporadic, most retail pharmacies don't stock it regularly. The product itself is available through pharmaceutical wholesalers — pharmacies just need to order it. Ask your pharmacy to place a special order; it typically arrives within 1-2 business days.
Head lice infestations typically spike in late August and September when school resumes, and again in January. During these periods, demand for prescription lice treatments including Ovide can temporarily outpace local pharmacy stocks. Planning ahead by getting prescriptions filled before peak season can help.
In some cases, yes. Generic malathion lotion 0.5% (FDA-approved since 2009) may be stocked by certain pharmacies that don't carry brand-name Ovide. Always ask your pharmacist for both options when searching for this medication.
If you've exhausted local options, consider mail-order pharmacy services (Express Scripts, CVS Caremark, OptumRx) or ask your doctor about alternatives. Spinosad (Natroba) and ivermectin lotion (Sklice) are effective, ovicidal prescription alternatives that are more widely stocked than Ovide.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Ovide also looked for:
More about Ovide
30,141 have already found their meds with Medfinder.
Start your search today.





